Cargando…

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

PURPOSE: To examine the evidence on the cost-effectiveness of implementing pharmacogenomics (PGx) in cardiovascular disease (CVD) care. METHODS: We conducted a systematic review using multiple databases from inception to 2018. The titles and abstracts of cost-effectiveness studies on PGx-guided trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ye, Swanson, Kristi M., Rojas, Ricardo L., Wang, Zhen, St. Sauver, Jennifer L., Visscher, Sue L., Prokop, Larry J., Bielinski, Suzette J., Wang, Liewei, Weinshilboum, Richard, Borah, Bijan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2019
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056639/ https://www.ncbi.nlm.nih.gov/pubmed/31591509 http://dx.doi.org/10.1038/s41436-019-0667-y

Ejemplares similares

Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort
por: Swanson, Kristi M., et al.
Publicado: (2020)

A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
por: Zhu, Ye, et al.
Publicado: (2020)

Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events
por: Zhu, Ye, et al.
Publicado: (2021)

Are patients willing to incur out of pocket costs for pharmacogenomic testing?
por: Bielinski, Suzette J., et al.
Publicado: (2016)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

An assessment of patient perspectives on pharmacogenomics educational materials
por: Asiedu, Gladys B, et al.
Publicado: (2020)

Metformin Pharmacogenomics: Biomarkers to Mechanisms
por: Wang, Liewei, et al.
Publicado: (2014)

Multidisciplinary Model to Implement Pharmacogenomics at the Point of Care
por: Caraballo, Pedro J., et al.
Publicado: (2016)

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017)

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
por: Giri, Jyothsna, et al.
Publicado: (2019)

Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol
por: Olson, Janet E., et al.
Publicado: (2017)

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
por: Takahashi, Paul Y, et al.
Publicado: (2021)

Developing a standardized healthcare cost data warehouse
por: Visscher, Sue L., et al.
Publicado: (2017)

Cost‐effectiveness of the Collaborative Care to Preserve Performance in Cancer (COPE) trial tele‐rehabilitation interventions for patients with advanced cancers
por: Longacre, Colleen F., et al.
Publicado: (2020)

Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics Hypothesis
por: Breitenstein, Matthew K., et al.
Publicado: (2015)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis
por: Uittenboogaard, Aniek, et al.
Publicado: (2022)

Cost analysis and complication rate comparing open, mini-open, and all arthroscopic rotator cuff repair
por: Marigi, Erick M., et al.
Publicado: (2021)

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
por: Takahashi, Paul Y, et al.
Publicado: (2021)

Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics
por: Lopes, Guilherme S, et al.
Publicado: (2020)

Impact of Diverse Data Sources on Computational Phenotyping
por: Wang, Liwei, et al.
Publicado: (2020)

Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review
por: Seshadri, Ashok, et al.
Publicado: (2022)

Multivariate models to detect genomic signatures for a class of drugs: application to thiopurines pharmacogenomics
por: Fridley, B L, et al.
Publicado: (2012)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
por: Liu, Duan, et al.
Publicado: (2017)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Health Care Utilization and Death in Patients With Heart Failure During the COVID-19 Pandemic
por: Manemann, Sheila M., et al.
Publicado: (2023)

CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
por: St Sauver, Jennifer L, et al.
Publicado: (2017)

Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota
por: Lopes, Guilherme S., et al.
Publicado: (2022)

Incidence and cost analysis of hospital admission and 30‐day readmission among patients with cirrhosis
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2018)

Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
por: St Sauver, Jennifer L, et al.
Publicado: (2023)

Sex differences in type and occurrence of adverse reactions to opioid analgesics: a retrospective cohort study
por: Lopes, Guilherme S, et al.
Publicado: (2021)

Using a pharmacogenomic algorithm to guide the treatment of depression
por: Hall-Flavin, D K, et al.
Publicado: (2012)

Leveraging multi-source to resolve inconsistency across pharmacogenomic datasets in drug sensitivity prediction
por: Das, Trisha, et al.
Publicado: (2023)

Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Implantable Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: A Systematic Review of Prospective Studies
por: Char, Steven, et al.
Publicado: (2022)

Cost-Effectiveness of Proton Beam Therapy for Intraocular Melanoma
por: Moriarty, James P., et al.
Publicado: (2015)

Artificial Intelligence-based Efficacy Prediction of Phase 3 Clinical Trial for Repurposing Heart Failure Therapies
por: Zong, Nansu, et al.
Publicado: (2023)

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
por: Wigle, Theodore J., et al.
Publicado: (2017)

Variability in Lipid Levels and Risk for Cardiovascular Disease: An Electronic Health Record–Based Population Cohort Study
por: Manemann, Sheila M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tof3gh1u2c65mq2au95ge837qm